MetLife Inc (MET)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NYSE
Market Cap: $64.51B
Last updated: Nov 17, 2026 at 11:06 AM ET
MetLife Inc (MET) Financials: Revenue, Profit and Cash Flow
MetLife reported revenue of $77.59B for the fiscal year ended Dec 31, 2025, up 9.3% from the year before. That year, net income was $3.40B with a net margin of 4.4%, operating cash flow was $17.09B and free cash flow was $17.09B. The quarter ended Sep 30, 2026 had revenue of $20.84B and net income of $2.41B.
Revenue and Margins
The operating margin was 6.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $60.79B, a compound annual rate of 2.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $77.59B | +9.3% | 36.1% | 6.0% | 4.4% |
| Dec 2024 | $70.99B | +4.5% | 28.2% | 9.4% | 6.3% |
| Dec 2023 | $67.90B | -6.3% | 25.5% | 3.2% | 2.4% |
| Dec 2022 | $72.44B | +5.5% | 26.1% | 8.8% | 7.3% |
| Dec 2021 | $68.70B | +1.3% | 24.5% | 12.4% | 10.0% |
| Dec 2020 | $67.84B | -2.6% | 22.8% | 10.2% | 8.0% |
| Dec 2019 | $69.62B | +2.5% | 23.3% | 9.8% | 8.5% |
| Dec 2018 | $67.94B | +9.0% | 23.4% | 9.3% | 7.5% |
| Dec 2017 | $62.31B | +2.5% | 21.6% | 5.7% | 6.5% |
| Dec 2016 | $60.79B | N/A | 23.0% | 7.0% | 1.4% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 23.4% from the year before. In the quarter ended Sep 2026, net income rose 167.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77.59B | $70.99B | $67.90B | $72.44B | $68.70B | $67.84B | $69.62B | $67.94B | $62.31B | $60.79B |
| Cost of revenue | $49.06B | $50.94B | $50.42B | $49.03B | $46.53B | $52.42B | $53.43B | $52.04B | $48.85B | $46.57B |
| Gross profit | $28.02B | $20.04B | $17.29B | $18.94B | $16.84B | $15.47B | $16.19B | $15.90B | $13.46B | $13.96B |
| Operating income | $4.66B | $6.66B | $2.16B | $6.36B | $8.52B | $6.93B | $6.79B | $6.31B | $3.54B | $4.28B |
| Net income | $3.40B | $4.44B | $1.60B | $5.30B | $6.88B | $5.42B | $5.91B | $5.13B | $4.02B | $854.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.84B | $19.42B | $18.95B | $24.05B | $17.62B | $17.62B | $18.27B | $18.50B | $17.91B | $17.82B | $16.75B | $20.21B |
| Gross profit | N/A | N/A | $7.10B | $7.27B | $2.94B | $4.54B | $4.72B | $4.86B | $5.45B | $4.39B | $4.49B | $3.17B |
| Operating income | N/A | N/A | $1.51B | $1.12B | $1.21B | $980.00M | $1.35B | $1.38B | $1.99B | $1.20B | $1.04B | $941.00M |
| Net income | $2.41B | $779.00M | $1.16B | $816.00M | $902.00M | $735.00M | $950.00M | $1.27B | $1.34B | $953.00M | $875.00M | $614.00M |
Balance Sheet
As of Dec 2025, total debt of $37.65B exceeded cash and equivalents by $15.62B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B | $795.15B | $740.46B | $687.54B | $719.89B | $898.76B |
| Current assets | $179.59B | $143.04B | $350.62B | $335.49B | $388.01B | $396.38B | $368.71B | $23.34B | $21.09B | $37.95B |
| Cash and equivalents | $22.03B | $20.07B | $20.64B | $20.20B | $20.05B | $19.80B | $16.60B | $15.82B | $12.70B | $12.65B |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B | $720.33B | $674.08B | $634.58B | $661.02B | $831.06B |
| Short-term debt | $31.94B | $32.68B | $17.64B | $35.76B | $32.26B | $30.00B | $40.81B | $25.50B | $26.51B | $26.11B |
| Long-term debt | $5.71B | $3.64B | $19.35B | $3.87B | $17.86B | $18.60B | $4.14B | $17.04B | $19.95B | $20.88B |
| Shareholder equity | $28.40B | $27.45B | $30.02B | $29.88B | $67.48B | $74.56B | $66.14B | $52.74B | $58.68B | $67.53B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $744.61B | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B | $677.46B | $704.98B | $675.75B | $677.58B | $687.58B |
| Total liabilities | $721.89B | $731.41B | $715.41B | $716.25B | $690.53B | $674.54B | $660.56B | $649.75B | $673.81B | $648.21B | $648.78B | $657.33B |
| Cash and equivalents | $19.79B | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B | $20.07B | $21.77B | $20.79B | $19.84B | $20.64B |
| Shareholder equity | $22.23B | $27.44B | $27.32B | $28.40B | $28.94B | $27.68B | $27.49B | $27.45B | $30.89B | $27.25B | $28.54B | $30.02B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 100.0% of operating cash flow. Dividends and share repurchases together came to 26.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $17.09B | $14.60B | $13.72B | $13.04B | $12.35B | $11.64B | $13.79B | $11.74B | $12.28B | $14.77B |
| Capital expenditures | $0 | $0 | $1.17B | $0 | $4.36B | $4.27B | $5.65B | $7.07B | $4.56B | $8.53B |
| Free cash flow | $17.09B | $14.60B | $12.55B | $13.04B | $7.99B | $7.37B | $8.13B | $4.67B | $7.72B | $6.24B |
| Dividends paid | $1.70B | $1.73B | $1.76B | $1.78B | $1.84B | $1.86B | $1.82B | $1.82B | $1.82B | $1.84B |
| Share repurchases | $2.88B | $3.21B | $3.10B | $3.33B | $4.30B | $1.15B | $2.29B | $3.99B | $2.93B | $372.00M |
| Investing cash flow | -$15.61B | -$11.49B | -$10.25B | -$2.62B | -$11.19B | -$18.57B | -$17.59B | -$5.63B | -$16.88B | -$5.85B |
| Financing cash flow | $163.00M | -$3.13B | -$2.94B | -$9.95B | -$1.13B | $10.73B | $4.57B | -$2.80B | -$906.00M | -$3.50B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.00B | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B | $5.18B |
| Capital expenditures | N/A | N/A | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $383.00M |
| Free cash flow | N/A | N/A | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B | $4.17B | $3.49B | $2.33B | $4.80B |
Frequently Asked Questions About MET
What is MetLife's annual revenue?
MetLife reported revenue of $77.59B for the fiscal year ended Dec 31, 2025.
How fast is MetLife's revenue growing?
Revenue was up 9.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.3%.
Is MetLife profitable?
Yes. MetLife reported net income of $3.40B for the fiscal year ended Dec 31, 2025, with a net margin of 4.4%.
How much free cash flow does MET generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $17.09B minus capital expenditures of $0 produced free cash flow of $17.09B.
How much debt does MetLife have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $5.71B, short-term debt of $31.94B and cash and equivalents of $22.03B.
MET pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts